AUS
NZ
UK
CA
USA
IND
Highlights
- Blue Trust Inc. increased its stake in Genpact Limited by 8.7% in Q4, reflecting institutional confidence.
- Major financial firms, including JPMorgan Chase & Co. and Geode Capital Management LLC, expanded their holdings.
- Stock sales by company executives coincide with analyst updates and stock target adjustments.
Genpact Limited is gaining market attention as institutional investors increase their stakes and analysts adjust stock targets. With major financial firms expanding their holdings and company executives selling shares, market activity remains dynamic. Strong earnings performance and a growing global presence position Genpact as a key player in business process outsourcing, attracting continued investor interest.
Institutional Investment and Market Engagement
Genpact Limited (NYSE:G) has seen increased institutional interest, with Blue Trust Inc. raising its stake by nearly nine percent in the fourth quarter. This adjustment brought its total holdings to over five thousand five hundred shares, valued at approximately two hundred seventeen thousand dollars.
Other financial firms have also demonstrated confidence in Genpact’s performance. JPMorgan Chase & Co. significantly increased its stake by one hundred ninety-two percent in the third quarter, bringing its total holdings to over three million shares, valued at more than one hundred twenty-two million dollars. Additionally, Geode Capital Management LLC expanded its position by over twelve percent, now holding nearly three point seven million shares, worth approximately one hundred forty-eight million dollars.
Stock Transactions and Executive Activity
Recent stock transactions among company executives have been reported. Senior Vice President Piyush Mehta sold twelve thousand shares, reducing his ownership by more than seven percent. Additionally, CEO Balkrishan Kalra sold nine thousand shares, reflecting a decrease of over three percent in his stake.
In the past ninety days, company executives have collectively sold more than thirty-five thousand shares, amounting to approximately one point five six million dollars. These transactions have been disclosed through regulatory filings.
Financial Firm Evaluations and Stock Target Adjustments
Financial firms have revised their assessments of Genpact Limited, issuing a range of updated stock targets. Needham & Company LLC increased its price target from forty-two dollars to fifty-five dollars. Jefferies Financial Group also raised its evaluation, aligning with a target of fifty-five dollars. Despite these optimistic revisions, the stock maintains a consensus classification, with an overall price target of forty-four dollars and fifty cents.
Stock Performance and Financial Stability
Genpact’s stock opened at forty-eight dollars and ninety-four cents, operating within a one-year range between thirty dollars and twenty-three cents and forty-nine dollars and fifteen cents. Key financial metrics include a debt-to-equity ratio of zero point five zero, with liquidity ratios indicating a balanced financial position. The company currently holds a market capitalization of approximately eight point six three billion dollars, with a price-to-earnings ratio of thirteen point four four.
Recent earnings exceeded expectations, reporting earnings per share of seventy-five cents, supported by one point two one billion dollars in revenue for the quarter.
Company Operations and Market Presence
Genpact Limited operates across multiple regions, including India, North America, Latin America, and Europe. Specializing in business process outsourcing, the company serves industries such as financial services, consumer and healthcare, and high-tech manufacturing. With ongoing expansion and strategic investments, Genpact remains a key player in the global market, attracting sustained interest from institutional investors.
